¼¼°èÀÇ ÀǾàǰ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯ÁöÀÇ Ã¢¾à ´Ü°è Á¦ÈÞ Á¶°Ç ¹× °è¾à(2020-2025³â)
Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2025
»óǰÄÚµå : 1795398
¸®¼­Ä¡»ç : Current Partnering
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 2500+ Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,995 £Ü 7,030,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,995 £Ü 9,845,000
PDF (Multi User License - 2 to 5 Users) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 2-5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,995 £Ü 12,660,000
PDF (Company Wide License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÀǾàǰ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯ÁöÀÇ Ã¢¾à ´Ü°è Á¦ÈÞ Á¶°Ç ¹× °è¾à(2020-2025³â)

¼¼°èÀÇ ÀǾàǰ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯ÁöÀÇ Ã¢¾à ´Ü°è Á¦ÈÞ Á¶°Ç ¹× °è¾à(2020-2025³â)¡± º¸°í¼­´Â ±â¾÷ÀÌ Ã¢¾à ´Ü°è Á¦ÈÞ °Å·¡¿¡ ÀÓÇÏ´Â ¹æ¹ý°ú ÀÌÀ¯, ÀÌ·¯ÇÑ °è¾àÀ» ÁöÁöÇÏ´Â À繫Àû ¹× Àü·«Àû Á¶°Ç¿¡ ´ëÇØ, Á¾ÇÕÀûÀÌ°í µ¥ÀÌÅÍ ÁÖµµÀÇ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ÀÌ Áß¿äÇÑ »ê¾÷ ÀÚ¿øÀº Á¦¾à ¹× »ý¸í °øÇÐ ºÎ¹®¿¡¼­ ÃÊ±â ´Ü°è ÆÄÆ®³Ê½ÊÀ» Á¤ÀÇÇÏ´Â ±¸Á¶, Çù»ó ¿ªÇÐ ¹× À繫 °í·Á »çÇ׿¡ ´ëÇÑ ±íÀº ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.

½Å¾à ´Ü°è¿¡¼­ ¶óÀ̼±½Ì °è¾àÀº ÀϹÝÀûÀ¸·Î ¶óÀ̼¾½Ã¿¡°Ô ¶óÀ̼¾¼­ÀÇ Á¦Ç° ¶Ç´Â ±â¼úÀ» Ãß°¡·Î °³¹ßÇÒ ±Ç¸® ¶Ç´Â ¿É¼ÇÀ» ºÎ¿©ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ °è¾àÀº Á¾Á¾ °øµ¿ ¿¬±¸ °³¹ß(R&D)·Î ½ÃÀÛÇÏ¿© »ó¾÷È­ °è¾àÀ¸·Î À̾îÁú ¼ö ÀÖ´Â µî ¿©·¯ ¿ä¼Ò¸¦ Æ÷ÇÔÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â °Ç°­ °ü¸® ºÐ¾ß¿¡¼­ ÃֽŠÀÇ¾à ´Ü°è °è¾àÀÇ »ó¼¼ÇÑ ³»¿ªÀ» Á¦°øÇϰí, ±â¾÷ÀÌ ½ÃÀå µ¿ÇâÀ» ÆÄ¾ÇÇϰí, °æÀï °è¾à ±¸Á¶¸¦ Æò°¡Çϰí, ÀÚ»çÀÇ Çù»ó Àü·«À» ÃÖÀûÈ­ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

»ý¸í °øÇÐ ¹× Á¦¾à ȸ»çÀÇ °Å·¡ Á¦Á¶¾÷ü Çʼö ¸®¼Ò½º

¼¼°èÀÇ ÀǾàǰ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯ÁöÀÇ Ã¢¾à ´Ü°è Á¦ÈÞ Á¶°Ç ¹× °è¾à(2020-2025³â)¡± º¸°í¼­´Â ¹ÙÀÌ¿À ÀǾàǰÀÇ °Å·¡¿¡ Á¾»çÇÏ´Â »ç¾÷ °³¹ß, ¹ý¹«, À繫 Àü¹®°¡¿¡°Ô ÀÖ¾î ÇʼöÀûÀÎ ÀÚ¿øÀÔ´Ï´Ù.

Á¾ÇÕÀûÀÎ ÅëÂû·Â, ¹æ´ëÇÑ °Å·¡ µ¥ÀÌÅͺ£À̽º ¹× °è¾à ¹®¼­¿¡ Á÷Á¢ ¾×¼¼½ºÇÔÀ¸·Î½á ÀÌ º¸°í¼­´Â ´ÙÀ½°ú °°Àº ±Ã±ØÀû ÀÎ µµ±¸·Î À¯¿ëÇÕ´Ï´Ù.

ÀÌ º¸°í¼­ 1Àå¿¡¼­´Â ÀÇ¾à ´Ü°è µô¸ÞÀÌÅ·°ú Àü·«Àû °íÂû¿¡ ´ëÇÑ »ó¼¼ÇÑ ¿À¸®¿£Å×À̼ÇÀ» Á¦°øÇÕ´Ï´Ù.

Á¦1Àå - º¸°í¼­ µµÀÔ

Á¦2Àå - ±â¾÷ÀÌ Ã¢¾à ´Ü°è Á¦ÈÞ¿¡ ÀÓÇÏ´Â ÀÌÀ¯

Á¦3Àå - Àü·«Àû Á¢±Ù°ú °Å·¡ ±¸Á¶(»ç·Ê ¿¬±¸ Æ÷ÇÔ)

Á¦4Àå - ¾÷ÇÁ·ÐÆ®, ÀÌÁ¤Ç¥, ·Î¿­Æ¼¸¦ Æ÷ÇÔÇÑ °áÁ¦ Àü·«

Á¦5Àå - â¾à ´Ü°è¿¡¼­ µô ¸ÞÀÌÅ· ºÐ¼®(2020-2025³â)(¿¬º°, Ä¡·á ¿µ¿ªº°, ±â¼ú À¯Çüº°, ÁÖ¿ä µô Á¦Á¶¾÷üº°)

Á¦6Àå - Çìµå¶óÀÎ °¡Ä¡, °è¾à ÀϽñÝ, ¸¶ÀϽºÅæ Æ®¸®°Å, Ãæ¼ºµµ¸¦ Æ÷ÇÔÇÑ À繫 Á¶°ÇÀÇ »ó¼¼ ºÐ¼®

Á¦7Àå ÁÖ¿ä â¾à ´Ü°è ¾È°ÇÀÇ Çìµå¶óÀÎ ±Ý¾×º° ¸®ºä

Á¦8Àå °¡Àå Ȱ¹ßÇÑ Ã¢¾à ´Ü°è µô Á¦Á¶¾÷ü »óÀ§ 25°³»ç

Á¦9Àå â¾à ´Ü°è Á¦ÈÞ °è¾àÀÇ µ¥ÀÌÅͺ£À̽º

Á¦10Àå 2020³â ÀÌÈÄ¿¡ ¹ßÇ¥µÈ ¸ðµç â¾à ´Ü°è ¾È°ÇÀÇ Á¾ÇÕÀû µð·ºÅ丮

¼¼°èÀÇ ÀǾàǰ ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯ÁöÀÇ Ã¢¾à ´Ü°è Á¦ÈÞ Á¶°Ç ¹× °è¾à(2020-2025³â) º¸°í¼­´Â ÀÌÇϸ¦ Á¦°øÇÕ´Ï´Ù.

°¢ »ç°ÇÀÇ »öÀÎ

ÀÌ º¸°í¼­´Â »ç¿ë °¡´ÉÇÑ ÇÑ ½ÇÁ¦ °è¾à¼­¸¦ ºÐ¼®ÇÏ¿© ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ¸íÈ®ÇÑ ´äº¯À» Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

ÁÖ¿ä ¿ä¾à

Á¦1Àå ¼­·Ð

Á¦2Àå - ±â¾÷Àº ¿Ö â¾à ´Ü°è¿¡¼­ Á¦ÈÞÇϴ°¡

Á¦3Àå â¾à ´Ü°è °Å·¡ Àü·«°ú ±¸Á¶

Á¦4Àå - â¾à ´Ü°è ÆÄÆ®³Ê½Ê ÁöºÒ Àü·«

Á¦5Àå â¾à ´Ü°è °Å·¡ ¼º¸³ÀÇ µ¿Çâ

Á¦6Àå - â¾à ´Ü°è Á¦ÈÞÀÇ ÁöºÒ Á¶°Ç

Á¦7Àå - â¾à ´Ü°è ÁÖ¿ä °Å·¡

Á¦8Àå - °¡Àå Ȱ¹ßÇÑ Ã¢¾à ´Ü°è µô Á¦Á¶¾÷ü »óÀ§ 25°Ç

Á¦9Àå - â¾à ´Ü°è ÆÄÆ®³Ê °è¾à µð·ºÅ丮

Á¦10Àå °³¹ß ´Ü°èº° â¾à ´Ü°è °Å·¡ ¼º¸³

ºÎ·Ï

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025)

The Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers a comprehensive, data-driven analysis of how and why companies engage in discovery-stage partnering deals and the financial and strategic terms underpinning these agreements. This essential industry resource provides deep insights into the structure, negotiation dynamics, and financial considerations that define early-stage partnerships in the pharmaceutical and biotech sectors.

At the discovery stage, licensing agreements typically grant the licensee rights or options to further develop a licensor's product or technology. These agreements are often multi-component, beginning with collaborative research and development (R&D) and potentially leading to commercialization agreements.

This report provides a detailed breakdown of the latest discovery-stage agreements in the healthcare sector, helping companies identify market trends, evaluate competitive deal structures, and optimize their own negotiation strategies.

A Must-Have Resource for Biotech and Pharma Dealmakers

The Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report is an indispensable resource for business development, legal, and financial professionals involved in biopharma dealmaking.

With comprehensive insights, a vast deal database, and direct access to contract documents, this report serves as the ultimate tool for:

The first chapters of the report provide a detailed orientation to discovery-stage deal-making and strategic considerations:

Chapter 1 - Introduction to the report

Chapter 2 - Why companies engage in discovery-stage partnerships

Chapter 3 - Strategic approaches and deal structures, with case studies

Chapter 4 - Payment strategies, including upfronts, milestones, and royalties

Chapter 5 - Discovery-stage deal-making analysis (2020-2025), categorized by year, therapeutic area, technology type, and key dealmakers

Chapter 6 - Detailed analysis of financial terms, including headline values, upfront payments, milestone triggers, and royalty rates

Chapter 7 - A review of the leading discovery-stage deals by headline value

Chapter 8 - The top 25 most active discovery-stage dealmakers

Chapter 9 - A database of discovery-stage partnering agreements, including contract documents where available

Chapter 10 - A comprehensive directory of all discovery-stage deals announced since 2020

The Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report provides:

Each deal record is indexed by:

By analyzing actual contract agreements where available, this report provides definitive answers to critical questions such as:

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Why do companies partner at discovery stage?

Chapter 3 - Discovery stage deal strategies and structure

Chapter 4 - Discovery stage partnering payment strategies

Chapter 5 - Trends in discovery stage deal making

Chapter 6 - Payment terms for discovery stage partnering

Chapter 7 - Leading discovery stage deals

Chapter 8 - Top 25 most active discovery stage dealmakers

Chapter 9 - Discovery stage partnering contracts directory

Chapter 10 - Discovery stage deal making by development stage

Appendices

Table of figures

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â